HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Ling Lai Selected Research

Colesevelam Hydrochloride (Welchol)

7/2010Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
7/2010Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
4/2010The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study.
1/2010Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy.
9/2009Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
11/2006Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Ling Lai Research Topics

Disease

5Type 2 Diabetes Mellitus (MODY)
07/2010 - 09/2009
3Hypercholesterolemia
07/2010 - 11/2006
2Abnormal Karyotype
03/2013 - 06/2012
2Prediabetic State (Prediabetes)
07/2010 - 09/2009
1Glioblastoma (Glioblastoma Multiforme)
05/2021
1Fetal Death
06/2012
1Chromosome Aberrations (Chromosome Abnormalities)
06/2012
1Insulin Resistance
04/2010
1Glucose Intolerance
09/2009
1Hyperglycemia
09/2009
1Coronary Disease (Coronary Heart Disease)
11/2006

Drug/Important Bio-Agent (IBA)

6Colesevelam Hydrochloride (Welchol)FDA Link
07/2010 - 11/2006
4LDL CholesterolIBA
07/2010 - 11/2006
4LipidsIBA
07/2010 - 09/2009
3Glucose (Dextrose)FDA LinkGeneric
07/2010 - 09/2009
3oxidized low density lipoproteinIBA
07/2010 - 11/2006
3Metformin (Glucophage)FDA LinkGeneric
07/2010 - 09/2009
2Pharmaceutical PreparationsIBA
06/2012 - 09/2009
2Lipoproteins (Lipoprotein)IBA
01/2010 - 09/2009
1Temozolomide (Temodar)FDA LinkGeneric
05/2021
1Histone Deacetylases (Histone Deacetylase)IBA
05/2021
1CateninsIBA
05/2021
1Biomarkers (Surrogate Marker)IBA
03/2013
1Hemoglobins (Hemoglobin)IBA
07/2010
1Bile Acids and Salts (Bile Acids)IBA
07/2010
1Triglycerides (Triacylglycerol)IBA
07/2010
1Insulin (Novolin)FDA Link
04/2010
1Sitagliptin Phosphate (Januvia)FDA Link
01/2010
1Rosiglitazone (Avandia)FDA Link
01/2010
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2009
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2006
1Ezetimibe (Zetia)FDA Link
11/2006

Therapy/Procedure

3Therapeutics
07/2010 - 11/2006
1Glycemic Control
01/2010
1Drug Therapy (Chemotherapy)
09/2009